Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|March 12, 2022
The dosimetric advantages of perirectal hydrogel spacer in men with localized prostate cancer undergoing stereotactic ablative radiotherapy (SABR)Philippa Sturt, Yae-Eun Suh, Vincent Khoo
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 12, 2023
Interobserver variation in clinical target volume (CTV) delineation for stereotactic radiotherapy to non-spinal bone metastases in prostate cancer: CT, MRI and PET/CT fusionEwan Richard Chapman, Luke Nicholls, Yae-Eun Suh, et al.
Oral Oncology|January 18, 2014
Patients with HPV-related tonsil squamous cell carcinoma rarely harbour oncogenic HPV infection at other pharyngeal sitesSelvam Thavaraj, Angela Stokes, Kazuya Mazuno, et al.
Clinical and Translational Radiation Oncology|November 4, 2020
Stereotactic radiotherapy with focal boost for intermediate and high-risk prostate cancer: Initial results of the SPARC trialLuke Nicholls, Yae-Eun Suh, Ewan Chapman, et al.
International Journal of Cancer|December 20, 2014
MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistanceYae-Eun Suh, Nina Raulf, Joop Gäken, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2025
Predictors of Long-Term Disease-Free Survival With Stereotactic Body Radiation Therapy for Oligometastatic Prostate CancerBinnaz Yasar, Ewan Chapman, Helen Taylor, et al.
British Journal of Cancer|March 22, 2017
Association between hypoxic volume and underlying hypoxia-induced gene expression in oropharyngeal squamous cell carcinomaYae-Eun Suh, Katherine Lawler, Rhonda Henley-Smith, et al.
Clinical and Translational Radiation Oncology|June 14, 2024
Weekly ultra-hypofractionated radiotherapy in localised prostate cancerNora Sundahl, Douglas Brand, Chris Parker, et al.
Clinical and Translational Radiation Oncology|January 15, 2026
Salvage stereotactic MR-Guided adaptive radiotherapy (SMART) re-irradiation for locally recurrent prostate Cancer: Clinical and dosimetric outcomesElena Moreno-Olmedo, Dan Murray, Ben George, et al.
Pageof 2